Titan Pharmaceuticals Statistics
Total Valuation
TTNP has a market cap or net worth of $6.13 million. The enterprise value is $3.33 million.
| Market Cap | 6.13M |
| Enterprise Value | 3.33M |
Important Dates
The last earnings date was Thursday, August 14, 2025, after market close.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TTNP has 1.33 million shares outstanding. The number of shares has increased by 16.31% in one year.
| Current Share Class | 1.33M |
| Shares Outstanding | 1.33M |
| Shares Change (YoY) | +16.31% |
| Shares Change (QoQ) | +16.52% |
| Owned by Insiders (%) | 38.09% |
| Owned by Institutions (%) | 3.56% |
| Float | 823,522 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.20 |
| P/TBV Ratio | 2.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.60
| Current Ratio | 11.60 |
| Quick Ratio | 11.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -82.72% and return on invested capital (ROIC) is -48.11%.
| Return on Equity (ROE) | -82.72% |
| Return on Assets (ROA) | -44.08% |
| Return on Invested Capital (ROIC) | -48.11% |
| Return on Capital Employed (ROCE) | -93.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$701,250 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.14% in the last 52 weeks. The beta is 1.41, so TTNP's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | +12.14% |
| 50-Day Moving Average | 4.38 |
| 200-Day Moving Average | 4.05 |
| Relative Strength Index (RSI) | 56.09 |
| Average Volume (20 Days) | 182,557 |
Short Selling Information
The latest short interest is 35,404, so 2.66% of the outstanding shares have been sold short.
| Short Interest | 35,404 |
| Short Previous Month | 58,677 |
| Short % of Shares Out | 2.66% |
| Short % of Float | 4.30% |
| Short Ratio (days to cover) | 0.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.61M |
| Pretax Income | -2.81M |
| Net Income | -2.81M |
| EBITDA | -2.61M |
| EBIT | -2.61M |
| Earnings Per Share (EPS) | -$2.95 |
Balance Sheet
The company has $2.80 million in cash and n/a in debt, giving a net cash position of $2.80 million or $2.11 per share.
| Cash & Cash Equivalents | 2.80M |
| Total Debt | n/a |
| Net Cash | 2.80M |
| Net Cash Per Share | $2.11 |
| Equity (Book Value) | 2.79M |
| Book Value Per Share | 2.10 |
| Working Capital | 2.79M |
Cash Flow
| Operating Cash Flow | -2.75M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.75M |
| FCF Per Share | -$2.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TTNP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.31% |
| Shareholder Yield | -16.31% |
| Earnings Yield | -45.74% |
| FCF Yield | -44.78% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 9, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jan 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |